Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.6410
+0.00961.52%
Post-market: 0.6290-0.0120-1.87%19:46 EDT
Volume:110.93K
Turnover:70.40K
Market Cap:4.62M
PE:-0.57
High:0.6448
Open:0.6149
Low:0.6116
Close:0.6314
Loading ...
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Correspondence

Form CORRESP - Correspondence
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 30, 2025

Correspondence

Form CORRESP - Correspondence
Apr 29, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 29, 2025

Correspondence

Form CORRESP - Correspondence
Apr 25, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Correspondence

Form CORRESP - Correspondence
Aug 21, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors